Sanara MedTech Inc.

NASDAQ:SMTI

Medical - Instruments & Supplies

Healthcare
$32.73 +3.44%

+$0.73 today

Market cap
$300.55M
Beta
1.19
P/E (TTM)
-5.7
EPS (TTM)
-$3.86
52W Low $16.05High $35.95

Volume 0.07M

Average 0.06M

SMTI Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Sanara MedTech Inc.NASDAQ: SMTI

Gross Margin · Q1 FY2026 · quarter ended Mar 2026

Gross margin widens to 91.0%

Gross margin was 91.0% in Q1 FY2026, up 1.8 pp from a year earlier. On a trailing-twelve-month basis it was 91.2%, up 0.8 pp year over year. Over 3 fiscal years it widened by 4.0 pp.

Context

  • Gross margin widened in 2 of the last 3 fiscal years.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
91.0%+0.2 pp QoQ
Last fiscal yearDec 2025
90.1%-0.5 pp YoY
LTMMar 2026
91.2%+0.8 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+1.8 pp——
1 year-0.5 pp——
3 years+4.0 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
90.1%
Year-over-year change
-0.5pp

Gross Margin vs competitors

How SMTI compares with its peers on the latest reported figures

  • SMTI's LTM Mar 2026 gross margin of 91.2% is the highest of the 10 companies compared; the peer median is 53.9%.
  • Its year-over-year change of +0.8 pp is the highest of 10, against a peer median of -1.0 pp.
  • Over three fiscal years its change of +4.0 pp compares with a peer median of -0.2 pp.
SMTI Competitors Peer median
Gross Margin for SMTI and competitors
Company Period LTM level YoY 3-year change
SMTISanara MedTech Inc.LTM Mar 202691.2% +0.8 pp+4.0 pp
SGHTSight Sciences, Inc.LTM Mar 202686.2% +0.5 pp+3.5 pp
LFMDLifeMD, Inc.LTM Mar 202685.9% -2.1 pp-4.6 pp
XGNExagen Inc.LTM Mar 202658.3% -1.0 pp+11.4 pp
VMDViemed Healthcare, Inc.LTM Mar 202657.3% -1.4 pp-3.5 pp
STXSStereotaxis, Inc.LTM Mar 202653.9% +0.5 pp-12.9 pp
TBRGTruBridge, Inc.LTM Mar 202651.2% -0.9 pp+4.0 pp
NEONeoGenomics, Inc.LTM Jun 202642.9% -1.0 pp+2.0 pp
HITIHigh Tide Inc.LTM Apr 202617.5% -8.3 pp-2.4 pp
TRDAEntrada Therapeutics, Inc.LTM Mar 2026-598.0% -698.0 pp—
Peer median (excluding SMTI) 53.9%-1.0 pp-0.2 pp

Competitors are the stored peer set for SMTI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue24.14M45.84M64.99M86.67M103.12M
Cost of Revenue2.31M6.36M7.85M8.14M10.18M
Gross Profit21.83M39.48M57.14M78.53M92.94M
Gross Margin90.4%86.1%87.9%90.6%90.1%
Research & Development558.7K3.37M4.13M5.7M5.07M
Selling, General & Admin28.05M45.98M56.99M76.56M78.72M
Operating Expenses29.21M52M61.35M85.25M83.79M
Depreciation & Amortization771.93K2.37M3.68M4.92M2.66M
EBITDA(7.22M)(11.57M)(289.1K)(1.86M)9.03M
EBITDA Margin-29.9%-25.2%-0.4%-2.1%8.8%
Operating Income(7.38M)(12.52M)(4.22M)(6.72M)9.15M
Operating Margin-30.6%-27.3%-6.5%-7.7%8.9%
Interest Income0284.75K021.98K3.67K
Interest Expense711284.75K475.78K3.13M6.76M
Other Income / Expenses(617.64K)(1.42M)(224.75K)(3.2M)(9.54M)
Income Before Tax(7.99M)(13.94M)(4.44M)(9.91M)(393.12K)
Pre-Tax Margin-33.1%-30.4%-6.8%-11.4%-0.4%
Income Tax Expense0(5.84M)000
Net Income(7.92M)(7.94M)(4.3M)(9.66M)(37.56M)
Net Margin-32.8%-17.3%-6.6%-11.2%-36.4%
EPS (Basic)(1.08)(1.00)(0.52)(1.14)(4.36)
EPS (Diluted)(1.08)(1.00)(0.52)(1.14)(4.36)
Weighted Avg Shares7.34M7.91M8.28M8.48M8.62M
Weighted Avg Shares (Diluted)7.34M7.91M8.28M8.48M8.62M

Sanara MedTech Inc.

NASDAQ:SMTI

Intrinsic Alpha fair value

Locked

Current Price

$32.73

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.